Azar Tapped: Stakeholders Heap Praise On Trump HHS Nominee
The administration's nominee to head HHS is being praised by medtech health-care industry lobbyists but may experience some pushback in the Senate because of his ties to Eli Lilly.
You may also be interested in...
Former HHS No. 2 would bring extensive knowledge of the sprawling department and policy expertise in the drug pricing area, where the Trump Administration is readying new actions.
AdvaMed CEO Scott Whitaker says Alex Azar, who is reportedly the top candidate to be nominee for US Health and Human Services secretary, would be ideal for the job with his extensive experience at the department.
A new House bill seeks to even the playing field so that third-party service providers are subject to similar FDA oversight to what manufacturers face when servicing their own devices.